Literature DB >> 17516097

Identification of (eta6-arene)ruthenium(II) protein binding sites in E. coli cells by combined multidimensional liquid chromatography and ESI tandem mass spectrometry: specific binding of [(eta6-p-cymene)RuCl2 (DMSO)] to stress-regulated proteins and to helicases.

Joanna Will1, Andreas Kyas, William S Sheldrick, Dirk Wolters.   

Abstract

An automated multidimensional protein identification technology, which combines biphasic liquid chromatography with electrospray ionisation tandem mass spectrometry (MS/MS), was employed to analyse tryptic peptides from Escherichia coli cells treated with the antiproliferation agent [(eta(6)-p-cymene)RuCl(2)(DMSO)], where DMSO is dimethyl sulfoxide. MS/MS spectra were recorded for molecular ions generated by neutral loss of p-cymene from intensive peptide ions coordinated by the (eta(6)-p-cymene)Ru(II) fragment. Matching of the MS/MS spectra of the ruthenated peptides to spectra of proteins in the E. coli database enabled the identification of five protein targets for [(eta(6)-p-cymene)RuCl(2)(DMSO)]. One of these is the constitutive cold-shock protein cspC, which regulates the expression of genes encoding stress-response proteins, and three of the other targets, ppiD, osmY and sucC, are proteins of the latter type. The DNA damage-inducible helicase dinG was likewise established as a protein target. Aspartate carboxylate functions were identified as the probable Ru binding sites in cspC, ppiD and dinG, and threonine and lysine side chains in osmY and sucC, respectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516097     DOI: 10.1007/s00775-007-0242-x

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  34 in total

1.  Thermal stability and atomic-resolution crystal structure of the Bacillus caldolyticus cold shock protein.

Authors:  U Mueller; D Perl; F X Schmid; U Heinemann
Journal:  J Mol Biol       Date:  2000-04-07       Impact factor: 5.469

2.  The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapy.

Authors:  Isam Khalaila; Alberta Bergamo; Francois Bussy; Gianni Sava; Paul J Dyson
Journal:  Int J Oncol       Date:  2006-07       Impact factor: 5.650

Review 3.  Mechanisms of helicases.

Authors:  Smita S Patel; Ilker Donmez
Journal:  J Biol Chem       Date:  2006-05-02       Impact factor: 5.157

4.  Diversity in guanine-selective DNA binding modes for an organometallic ruthenium arene complex.

Authors:  Hong-Ke Liu; Susan J Berners-Price; Fuyi Wang; John A Parkinson; Jingjing Xu; Juraj Bella; Peter J Sadler
Journal:  Angew Chem Int Ed Engl       Date:  2006-12-11       Impact factor: 15.336

5.  The complete genome sequence of Escherichia coli K-12.

Authors:  F R Blattner; G Plunkett; C A Bloch; N T Perna; V Burland; M Riley; J Collado-Vides; J D Glasner; C K Rode; G F Mayhew; J Gregor; N W Davis; H A Kirkpatrick; M A Goeden; D J Rose; B Mau; Y Shao
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

Review 6.  The Escherichia coli proteome: past, present, and future prospects.

Authors:  Mee-Jung Han; Sang Yup Lee
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

Review 7.  Metal-based antitumour drugs in the post genomic era.

Authors:  Paul J Dyson; Gianni Sava
Journal:  Dalton Trans       Date:  2006-03-28       Impact factor: 4.390

8.  Universal nucleic acid-binding domain revealed by crystal structure of the B. subtilis major cold-shock protein.

Authors:  H Schindelin; M A Marahiel; U Heinemann
Journal:  Nature       Date:  1993-07-08       Impact factor: 49.962

9.  pH-dependent expression of periplasmic proteins and amino acid catabolism in Escherichia coli.

Authors:  Lauren M Stancik; Dawn M Stancik; Brian Schmidt; D Michael Barnhart; Yuliya N Yoncheva; Joan L Slonczewski
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

10.  Highly selective binding of organometallic ruthenium ethylenediamine complexes to nucleic acids: novel recognition mechanisms.

Authors:  Haimei Chen; John A Parkinson; Robert E Morris; Peter J Sadler
Journal:  J Am Chem Soc       Date:  2003-01-08       Impact factor: 15.419

View more
  8 in total

1.  Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound.

Authors:  Angela Casini; Chiara Gabbiani; Elena Michelucci; Giuseppe Pieraccini; Gloriano Moneti; Paul J Dyson; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2009-03-14       Impact factor: 3.358

2.  Reaction of the Anticancer Organometallic Ruthenium Compound, [(eta-p-Cymene)Ru(ATSC)Cl]PF(6) with Human Serum Albumin.

Authors:  Floyd A Beckford
Journal:  Int J Inorg Chem       Date:  2010-01-01

3.  Reactivity of anticancer metallodrugs with serum proteins: new insights from size exclusion chromatography-ICP-MS and ESI-MS.

Authors:  Michael Groessl; Mattia Terenghi; Angela Casini; Lisa Elviri; Ryszard Lobinski; Paul J Dyson
Journal:  J Anal At Spectrom       Date:  2010-03       Impact factor: 4.023

4.  Characterisation of cisplatin coordination sites in cellular Escherichia coli DNA-binding proteins by combined biphasic liquid chromatography and ESI tandem mass spectrometry.

Authors:  Joanna Will; William S Sheldrick; Dirk Wolters
Journal:  J Biol Inorg Chem       Date:  2007-12-22       Impact factor: 3.358

5.  Competitive binding sites of a ruthenium arene anticancer complex on oligonucleotides studied by mass spectrometry: ladder-sequencing versus top-down.

Authors:  Kui Wu; Wenbing Hu; Qun Luo; Xianchan Li; Shaoxiang Xiong; Peter J Sadler; Fuyi Wang
Journal:  J Am Soc Mass Spectrom       Date:  2013-02-13       Impact factor: 3.109

Review 6.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

Review 7.  The Protein-Binding Behavior of Platinum Anticancer Drugs in Blood Revealed by Mass Spectrometry.

Authors:  Jingchen Wang; Jianmei Tao; Shuailong Jia; Meiqin Wang; Hongliang Jiang; Zhifeng Du
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-29

8.  Sensitive Marker of the Cisplatin-DNA Interaction: X-Ray Photoelectron Spectroscopy of CL.

Authors:  Fangxing Xiao; Xiaobin Yao; Qianhong Bao; Danzhen Li; Yi Zheng
Journal:  Bioinorg Chem Appl       Date:  2012-10-24       Impact factor: 7.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.